Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2003
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues
03/05/2003EP1286674A1 Methods and compositions for potentiating cancer chemotherapeutic agents
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286671A2 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan
03/05/2003EP1286665A2 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
03/05/2003EP1286663A2 Encapsulating a toxic core within a non-toxic region in an oral dosage form
03/05/2003EP1286661A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
03/05/2003EP1286643A2 Drug containing polymeric micelles
03/05/2003EP1266661A9 Anticancer compositions
03/05/2003EP1210097B1 A pharmaceutical ayurvedic preparation
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1084569B1 Androgens in combination with gestagens for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
03/05/2003EP1082329B1 Platinum complex, its preparation and therapeutic application
03/05/2003EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
03/05/2003EP1054859A4 Processes and intermediates useful to make antifolates
03/05/2003EP0971692B1 Specific magnetosome, method for the production and use thereof
03/05/2003EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
03/05/2003EP0896577B1 Taxane derivatives having a Pyridyl substituted C13 side chain and their use as anti-tumor agents
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0869786B1 Pharmaceutical compounds
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0724457B1 Radiation sensitization using texaphyrins
03/05/2003CN1400976A Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400899A Use of 2-methyl thiazolidin-2, 4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400316A Collapsin reaction medium protein-1
03/05/2003CN1400298A Fruit kernel oil extracted from plant fruit kernel, its extraction method, medicinal composite and application
03/05/2003CN1400019A Transgene clone cancer-resisting and cancer-curing technology
03/05/2003CN1399999A Medicine for curing malignant turnor and its preparation method
03/05/2003CN1399988A Anti-tumor action of hymidine and research of its action mechanism
03/05/2003CN1399983A Prescription of protein medicine for curing carcinoma of stomach, intestinal cancer, carcinoma of esophagus and leukemia and its preparation method
03/05/2003CN1399982A Prescription of protein medicine for curing cancer of lung and mammary cancer and its preparation
03/05/2003CN1399981A Prescription of protein medicine for curing liver cancer and its preparation method
03/05/2003CN1399979A Chinese medicine composition for curing cancers
03/05/2003CN1399958A Taxol nano magnetic target preparation and its preparation method
03/05/2003CN1399957A Application of shikonin and its derivative in pharmaceutical industry
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/05/2003CA2356438A1 Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
03/04/2003WO2002020614A2 Endoglin-specific polypeptide, production and use thereof
03/04/2003US6528681 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
03/04/2003US6528664 Synthetic methods for polyphenols
03/04/2003US6528653 Thienopyrrolidinones
03/04/2003US6528637 Fatty acid synthase mRNA binding protein
03/04/2003US6528627 Bridged aromatic substituted amine ligands with donor atoms
03/04/2003US6528619 Cyclic peptide binding inhibitors; structural formulas; use drugs for diseases mediated by urokinase and receptor; tumors; inflammation; angiogenesis
03/04/2003US6528535 Bicyclic inhibitors of protein farnesyl transferase
03/04/2003US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation
03/04/2003US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity
03/04/2003US6528523 N-acyl- or N-sulfonylpiperidine substituted tricyclic benzocycloheptenepyridine derivatives
03/04/2003US6528515 Beta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (beta -FTC) and penciclovir
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528305 Method of producing infectious reovirus
03/04/2003US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications
03/04/2003US6528294 To effect protein phosphorylation; for use in diagnosis and therapy
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003CA2421202A1 Endoglin-specific polypeptide, production and use thereof
02/2003
02/27/2003WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof
02/27/2003WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016540A2 Humanised baculovirus
02/27/2003WO2003016532A1 Human protooncogene kg-20 and protein encoded therein
02/27/2003WO2003016530A1 Novel protein and its dna
02/27/2003WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis
02/27/2003WO2003016522A2 Methods and compounds for the targeting of protein to exosomes
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016499A2 Combinatorial methods for inducing cancer cell death
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016472A2 Hybrid interferon/interferon tau proteins, compositions and methods of use
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016464A2 Cancer specific oligosaccharide sequences and use thereof
02/27/2003WO2003016351A2 N - cam related compounds modulating cell groth
02/27/2003WO2003016348A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
02/27/2003WO2003016344A2 Use of lung carcinoma antigen
02/27/2003WO2003016318A1 Tumour inhibiting lanthane compounds
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016305A1 Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
02/27/2003WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
02/27/2003WO2003016288A1 Fxr nr1h4 nuclear receptor binding compounds
02/27/2003WO2003016270A2 Selective estrogen receptor modulators
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003015831A1 Gas microsphere liposome composites
02/27/2003WO2003015827A1 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof
02/27/2003WO2003015826A1 Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor
02/27/2003WO2003015825A2 Conjugate
02/27/2003WO2003015820A1 GnRH AGONIST COMBINATION DRUGS
1 ... 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 ... 2211